TER

Teradyne

$398.72

-3.17%
Oct 8, 2026
Bobby Quantitative Model
Teradyne, Inc. is a leading supplier of automated test equipment (ATE) for the semiconductor industry, alongside system testing for hard disk drives, circuit boards, and electronics, and a growing industrial automation segment selling collaborative and autonomous robots for factory applications. The company occupies a dominant, quasi-oligopolistic position in semiconductor test — particularly for complex logic and memory chips — serving vertically integrated, fabless, and foundry chipmakers, which makes it a critical enabler of the AI computing buildout rather than a direct chip producer. The current investor narrative is overwhelmingly centered on AI-driven demand: recent headlines highlight surging memory chip test demand, Q2 earnings and Q3 guidance that significantly exceeded expectations, and the stock's addition to the Nasdaq-100 as the index pivots toward AI-enabling companies. At the same time, the debate includes valuation risk and cyclicality — Michael Burry's high-profile semiconductor short and a sharp April selloff on margin-pressure guidance show that sentiment is not uniformly bullish, and the market is actively weighing whether AI test demand is a durable secular shift or a cyclical peak.

People also watch

Nvidia

Nvidia

NVDA

Analysis
Broadcom

Broadcom

AVGO

Analysis
Micron Technology

Micron Technology

MU

Analysis
AMD

AMD

AMD

Analysis
Intel

Intel

INTC

Analysis

BobbyInvestment Opinion: Should I buy TER Today?

We rate Teradyne a Hold. The company is a high-quality AI enabler with explosive growth (Q2 2026 revenue +103.9% YoY) and exceptional profitability (28.2% net margin), but the stock's valuation (forward P/E 38.5, PEG 23.6) already reflects much of the optimism. The analyst consensus is 'buy' with an average target of $446.47, essentially in line with the current price of $449.04, suggesting limited near-term upside.

The supporting evidence is strong: revenue growth is accelerating, gross margins are stable near 60%, free cash flow is robust at $799.9M TTM, and the balance sheet is pristine with debt-to-equity of 0.124. The stock's 210.7% one-year return and addition to the Nasdaq-100 highlight its momentum and market recognition. However, these positives are well-known and largely priced in.

The biggest risks are valuation compression, cyclical demand, and competitive pressures. A forward P/E of 38.5 is rich for a company in a cyclical industry, and any slowdown in AI capex could lead to a sharp correction. We would upgrade to Buy if the stock pulls back to the analyst low target of $350 (22% downside) or if forward P/E compresses below 30x while growth remains above 50%. We would downgrade to Sell if revenue growth decelerates below 20% or if gross margins fall below 55%. Relative to its history and peers, the stock appears overvalued, trading at a significant premium to the broader market and its own historical multiples.

Sign up to view all

TER 12-Month Price Forecast

Teradyne is a high-quality company at the center of the AI semiconductor test boom, with impressive financials and a strong competitive position. However, the stock's valuation already prices in significant growth, and the risk/reward is balanced. The analyst consensus target is essentially at the current price, suggesting limited upside without further positive catalysts. We would upgrade to bullish if the stock pulls back to the $350-380 range or if forward P/E compresses below 30x while growth remains robust. We would downgrade to bearish if revenue growth decelerates below 20% or if gross margins fall below 55%, signaling a cyclical downturn.

Historical Price
Current Price $398.72
Average Target $445.00
High Target $550.00
Low Target $300.00

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Teradyne's 12-month outlook, with a consensus price target around $446.47 and implied upside of +12.0% versus the current price.

Average Target

$446.47

0 analysts

Implied Upside

+12.0%

vs. current price

Analyst Count

—

covering this stock

Price Range

$350 - $550

Analyst target range

Drowning in data?

Find the real signal!

Bulls vs Bears: TER Investment Factors

The bull case for Teradyne is compelling: explosive AI-driven revenue growth (103.9% YoY in Q2 2026), exceptional margins (59.8% gross, 28.2% net), a fortress balance sheet (D/E 0.124), and strong analyst support (average target $446.47). However, the bear case is equally potent: extreme valuation (forward P/E 38.5, PEG 23.6), cyclical revenue lumpiness, high beta (1.778), and a high-profile short bet by Michael Burry. Currently, the bull evidence is stronger due to the tangible AI demand and stellar financials, but the single most important tension is whether AI test demand is a durable secular shift or a cyclical peak. If it proves cyclical, the stock could face a severe de-rating; if secular, the growth runway justifies the premium.

Bullish

  • AI-driven test demand accelerating: Q2 2026 revenue grew 103.9% YoY to $1.329B, with EPS of $2.39 versus $0.49 in the prior-year quarter. This explosive growth is directly tied to surging memory chip test demand, positioning Teradyne as a critical enabler of the AI computing buildout.
  • Exceptional profitability and cash generation: Q2 2026 gross margin reached 59.8%, operating margin 32.9%, and net margin 28.2%, while TTM free cash flow stands at $799.9M. These metrics demonstrate strong pricing power and operational leverage in a capital-intensive industry.
  • Fortress balance sheet with minimal debt: Debt-to-equity is just 0.124 and the current ratio is 1.76, providing ample financial flexibility. This low leverage reduces risk during cyclical downturns and supports continued investment in R&D ($156M in Q2 alone).
  • Analyst consensus and target upside: 15 analysts rate the stock a 'buy' with an average target of $446.47, implying modest upside from the current $449.04. The high target of $550 suggests potential for further appreciation if AI demand persists.

Bearish

  • Extreme valuation leaves no margin for error: Trailing P/E is 55.5, forward P/E 38.5, and EV/EBITDA 39.5, all at premium levels. The PEG ratio of 23.6 is exceptionally high, indicating that the market is pricing in aggressive future growth that may be difficult to sustain.
  • Cyclical revenue lumpiness and margin pressure: Despite blockbuster Q2 results, guidance signaled near-term margin pressure and revenue lumpiness, triggering a 15% single-day drop on April 29, 2026. The semiconductor test market is historically cyclical, and a downturn could rapidly erode earnings.
  • High beta amplifies market volatility: With a beta of 1.778, Teradyne is significantly more volatile than the broader market. Any sector rotation or macro headwind could lead to outsized declines, as evidenced by the 34% max drawdown over the past year.
  • Michael Burry's short bet signals sentiment risk: Michael Burry's high-profile short on the semiconductor sector (April 2026) highlights concerns that the AI-driven rally may be overextended. If institutional sentiment shifts, the stock could face a sharp correction given its high valuation and momentum-driven ownership.

TER Technical Analysis

Beta

1.75

1.75x market volatility

Max Drawdown

-34.0%

Largest decline past year

52-Week Range

$132-$488

Price range past year

Annual Return

+175.7%

Cumulative gain past year

PeriodTER ReturnS&P 500
1m+7.2%+1.0%
3m+10.9%+2.5%
6m+8.4%+13.9%
1y+175.7%+15.0%
ytd+92.1%+13.5%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

TER Fundamental Analysis

Quarterly Revenue

$1.3B

2026-06

Revenue YoY Growth

+103.9%

YoY Comparison

Gross Margin

59.8%

Latest Quarter

Free Cash Flow

$799932000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Product
Service

Open an Account, get $2 TSLA now!

Valuation Analysis: Is TER Overvalued?

PE

55.5x

Latest Quarter

vs. Historical

High-End

5-Year PE Range 17x~49x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

37.3x

Enterprise Value Multiple

Investment Risk Disclosure

Financial and operational risks are moderate but notable. Teradyne's debt-to-equity of 0.124 and current ratio of 1.76 indicate a healthy balance sheet, but the company operates in a cyclical industry where revenue can be lumpy. Q2 2026 revenue surged 103.9% YoY, but this follows a period of volatility, and guidance has signaled near-term margin pressure. Additionally, the company's net margin of 28.2% is impressive but could compress if pricing pressure intensifies or if R&D spending (which rose to $156M in Q2) fails to generate proportional returns. The concentration in semiconductor test equipment, which accounts for the majority of revenue, exposes Teradyne to the capital expenditure cycles of a handful of large chipmakers.

Market and competitive risks are significant. The stock trades at a forward P/E of 38.5 and EV/EBITDA of 39.5, well above historical averages and many peers, leaving little room for disappointment. With a beta of 1.778, Teradyne is highly sensitive to market swings, and any sector rotation away from AI enablers could trigger a sharp selloff. Michael Burry's short bet on semiconductors in April 2026 underscores the risk that the AI rally is overextended. Furthermore, competition from other test equipment providers, such as Advantest, could pressure pricing and market share, especially if AI chip demand moderates.

The worst-case scenario would involve a combination of a cyclical downturn in semiconductor demand, margin compression, and a valuation de-rating. If AI infrastructure spending slows, Teradyne's revenue could decline sharply, and the stock could fall to its 52-week low of $131.75, representing a 70.7% decline from the current price of $449.04. Even a more moderate bear case, such as the analyst low target of $350, implies a 22% downside. Given the high beta and momentum-driven ownership, a sentiment shift could accelerate losses, and investors should be prepared for significant volatility.

FAQ

The key risks include: 1) Valuation risk: forward P/E of 38.5 and PEG of 23.6 make the stock vulnerable to any growth disappointment. 2) Cyclical risk: semiconductor test demand is historically cyclical, and a downturn could lead to a 70% decline to the 52-week low of $131.75. 3) Competitive risk: rivals like Advantest could pressure pricing and market share. 4) Macro risk: high beta (1.778) means the stock is sensitive to market swings and sector rotation. Additionally, Michael Burry's short bet on semiconductors highlights sentiment risk.

Our 12-month forecast has three scenarios: Bull case (25% probability) targets $500-550, driven by continued AI demand and earnings beats. Base case (55% probability) targets $420-470, assuming moderate growth and stable margins. Bear case (20% probability) targets $300-350, reflecting a cyclical downturn or market correction. The base case is most likely, with the stock trading around the analyst average target of $446. The key assumption is that AI capex remains healthy but growth rates moderate, and margins hold steady.

Teradyne appears overvalued on most metrics. Its trailing P/E is 55.5, forward P/E 38.5, and EV/EBITDA 39.5, all at premium levels relative to the broader market and its own history. The PEG ratio of 23.6 is exceptionally high, suggesting the market expects aggressive growth. While the company's 103.9% YoY revenue growth in Q2 2026 justifies some premium, the valuation leaves little room for error. Compared to peers in the semiconductor equipment space, Teradyne trades at a significant premium, implying that the market has already priced in a lot of good news.

Teradyne is a high-quality AI enabler with explosive growth, but the current valuation offers a balanced risk/reward. The stock trades at $449.04, essentially at the analyst average target of $446.47, implying limited near-term upside. The bull case hinges on sustained AI-driven demand, while the bear case points to cyclicality and premium valuation. For long-term investors comfortable with volatility (beta 1.778), it could be a good buy on pullbacks. However, at current levels, the margin of safety is thin, and a 22% downside to the analyst low target of $350 is possible if growth slows.

Teradyne is more suitable for long-term investment (minimum 3-5 years) given its cyclical nature and the secular AI growth story. Short-term trading is risky due to high volatility (beta 1.778, max drawdown 34%) and event-driven swings around earnings. The company pays a negligible dividend (yield 0.25%), so returns depend on capital appreciation. Long-term investors can ride out cyclical downturns and benefit from the AI infrastructure buildout. However, position sizing should be conservative due to the high valuation and potential for sharp corrections.